Published in Hematology Week, September 5th, 2011
"Patients with cerebrovascular disease and hypertension at baseline (n = 4283) were randomly assigned to either active treatment (perindopril in all participants plus indapamide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2011-09-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.